Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience

  • Paola Anna Jablonska,
  • Ricardo Diez-Valle,
  • Jaime Gállego Pérez-Larraya,
  • Marta Moreno-Jiménez,
  • Miguel Ángel Idoate,
  • Leire Arbea,
  • Sonia Tejada,
  • Maria Reyes Garcia de Eulate,
  • Luis Ramos,
  • Javier Arbizu,
  • Pablo Domínguez,
  • José Javier Aristu
  • Article
  • Metrics
  • Comments
  • Media Coverage

There is an error in the XML of the article. As a result, the third author’s name is listed in the citation incorrectly. The correct citation is: Jablonska PA, Diez-Valle R, Gállego Pérez-Larraya J, Moreno-Jiménez M, Idoate MÁ, Arbea L, et al. (2019) Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience. PLoS ONE 14(6): e0217881. https://doi.org/10.1371/journal.pone.0217881

Reference

  1. 1. Jablonska PA, Diez-Valle R, Pérez-Larraya JG, Moreno-Jiménez M, Idoate MÁ, Arbea L, et al. (2019) Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience. PLoS ONE 14(6): e0217881. https://doi.org/10.1371/journal.pone.0217881 pmid:31170245

Citation: Jablonska PA, Diez-Valle R, Gállego Pérez-Larraya J, Moreno-Jiménez M, Idoate MÁ, Arbea L, et al. (2019) Correction: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience. PLoS ONE 14(7): e0219614. https://doi.org/10.1371/journal.pone.0219614

Published: July 8, 2019

Copyright: © 2019 Jablonska et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.